Fig. 6

Clinical significance of LIFR-AS1 in NSCLC. a Measurement of the expression levels of LIFR-AS1 in 73 pairs of NSCLC and corresponding noncancerous tissues. b Kaplan–Meier analysis based on lung adenocarcinoma TCGA dataset revealed that low expression of LIFR-AS1 was significantly correlated with a reduced overall survival. Statistical differences were determined by the log-rank test. c Schematic model showing that LIFR-AS1 sponges miR-942-5p to derepress ZNF471, consequently blocking NSCLC cell invasion and metastasis